The book deals with therapeutic monoclonal antibodies (mAbs) broadly, and relevant topics such as challenges and opportunities, next-generation antibody products, Antibody-Drug-Conjugates (ADC), bispecifics, glycosylation, and T-cell engagers are covered. Each topic has been written by leading groups around the world and the book should be of interest to researchers from both academia and industry.
Ik heb een vraag over het boek:
‘Monoclonal Antibody-Directed Therapy - Kayser, Veysel’.
Vul het onderstaande formulier in.
We zullen zo spoedig mogelijk antwoorden.
